Randy has now been in a clinical trial for 133 weeks. Yesterday was his quarterly check up at Emory. (The President was in Atlanta yesterday....can I tell you what that did to the traffic situation?) We went, as usual, to the upon arrival. As always, they took two sets of blood samples. One is for use by the docs at Emory and one is sent to the trial sponsor. Since this is a double-blind study, we nor the doctors know the results of the PSA test. The only exception to that have been when Randy's PSA reached undetectable the first time, we knew because treatment was discontinued, and when his PSA subsequently rose to 2.0, treatment was restarted. The protocol only allows for one "break" in treatment, so since he restarted we have been completely in the dark.
Yesterday, we went in to see the doctor and all went well. Usually the blood work results are in hand when the doctor comes into the room. Yesterday, they weren't, so we waited around for the results. After a while, our clinical trial rep came into the room with the results in hand. The first words out of her mouth were: "This is going to be an awkward conversation". (Queue the clenched stomach) But as it turns out, the news was good news. It seems that someone in the lab made a error and processed the samples for PSA. Medical ethics, we were told, require that we be informed of any test results that our doctors have access to, so for the first time in a long, long time, we know Randy's PSA. Drum-roll, please....0.01.
This is such a relief. Previously, I found a reference on his scan report that showed his diagnosis as "Prostate Cancer with Rising PSA". Although the PA assured us that the pathologists had no idea about his PSA, I was afraid that Randy was becoming castrate resistant. It turns out he's not. Yesterday was a good day (traffic not withstanding). Sometimes it's a good thing to know what you're not supposed to know. Now we're just hoping the person in the lab who dropped this particular ball doesn't get into too much trouble.